سعر سيفوزون 500مجم فيال 2024

Cefozon 500mg i.m./i.v. vial: Cefoperazone (Eipico).

• Parenteral third-generation cephalosporin historically used for susceptible infections including respiratory, urinary, skin, intra-abdominal and gynecologic infections (ingredient-level; modern US SPL for cefoperazone monotherapy not found on DailyMed in this pass).Population: AdultsWHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Hypersensitivity to cefoperazone or other cephalosporins/beta-lactams (ingredient-level references).General active-ingredient information · WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Bleeding/hypoprothrombinemia risk (especially with vitamin K deficiency); disulfiram-like reaction with alcohol; C. difficile–associated diarrhea; cross-allergy with penicillins (ingredient-level).General active-ingredient information · WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• AlcoholDisulfiram-like reaction possible for several days after therapy.WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)
• Anticoagulants / vitamin K deficiencyMay increase bleeding risk; monitor coagulation.WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Use in pregnancy only if clearly needed; limited human data (ingredient-level).General active-ingredient information · WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)
• Excreted in breast milk in low amounts; use caution (ingredient-level).General active-ingredient information · WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Cefoperazone: Semisynthetic broad-spectrum third-generation cephalosporin inhibiting cell-wall synthesis; extensively excreted in bile.